Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Mdb Capital Holdings LLC (MDBH) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Capital Markets
$3.25
-0.08 (-2.40%)Did MDBH Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if MDB Capital is one of their latest high-conviction picks.
MDBH has shown a year-to-date change of -48.4% and a 1-year change of -47.2%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MDBH. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MDBH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to MDB Capital based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Mdb Capital Holdings LLC has a market capitalization of $32.95M with a P/E ratio of 2.3x. The company generates $1.25M in trailing twelve-month revenue with a 913.8% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -300.2% and return on equity of +29.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Investment firm focused on emerging technologies.
The company identifies and invests in breakthrough innovations in sectors like biotechnology and life sciences. It provides financial backing and expertise to support companies during their early development stages, aiming to accelerate the commercialization of transformative technologies.
Mdb Capital Holdings LLC plays a critical role in connecting scientific advancements with market opportunities, significantly impacting industries such as healthcare and nanotechnology by facilitating the transition from research to commercialization.
Financial Services
Capital Markets
16
Mr. Christopher A. Marlett
United States
2023
MDB Capital Holdings will hold its Q3 2025 earnings call on November 20, 2025, at 4:30 PM EST, featuring key executives including CEO Christopher Marlett.
MDB Capital Holdings' Q3 2025 earnings call provides insights into financial performance and strategic direction, crucial for assessing investment potential and company growth trajectory.
MDB Capital Holdings (NASDAQ: MDBH) announced a $16.8 million private placement for Paulex Bio, focusing on diabetes therapeutics, expected to close soon.
MDB Capital's upcoming $16.8 million private placement for Paulex Bio signals potential growth in the biopharmaceutical sector, impacting MDBH's valuation and investor sentiment in innovative health solutions.
MDB Capital Holdings (NASDAQ: MDBH) will host a Zoom webinar on November 20, 2025, at 4:30 p.m. ET to discuss its Q3 2025 business update. A press release will precede the call.
MDB Capital Holdings' upcoming webinar and Q3 results could impact stock performance and investor sentiment, highlighting growth potential or challenges in their disruptive technology sector.
The latest PatentVest Pulse report provides insights into key players and trends in the cardiac diagnostics market, targeting investors, board members, and CEOs.
The PatentVest Pulse report highlights key players in the cardiac diagnostics market, providing insights into potential investment opportunities and competitive advantages.
LD Micro has announced MDB Capital Holdings as its 2,000th presenting company, marking a significant milestone for the platform since its inception in 2006.
The milestone of MDB becoming LD Micro's 2,000th presenting company signals growth in microcap investment opportunities, potentially attracting more investor interest and capital into emerging markets.
MDB Capital Holdings (NASDAQ: MDBH) will present at the 19th annual Main Event on October 21 at 10:30 AM PT in San Diego. CEO Chris Marlett will lead the presentation.
MDB Capital Holdings' presentation at a major event highlights its strategic initiatives and potential growth, influencing investor sentiment and stock performance.
Analyst forecasts for Mdb Capital Holdings LLC (MDBH) are not currently available. The stock is trading at $3.25.
Analyst ratings for MDBH are not currently available. The stock is currently trading at $3.25. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MDBH are not currently available. The stock is trading at $3.25.
The company identifies and invests in breakthrough innovations in sectors like biotechnology and life sciences. It provides financial backing and expertise to support companies during their early development stages, aiming to accelerate the commercialization of transformative technologies.
Price targets from Wall Street analysts for MDBH are not currently available. The stock is trading at $3.25.
Price targets from Wall Street analysts for MDBH are not currently available. The stock is trading at $3.25.
Analyst ratings for MDBH are not currently available. The stock is trading at $3.25.
Stock price projections, including those for Mdb Capital Holdings LLC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.